SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001731122-23-000651
Filing Date
2023-04-14
Accepted
2023-04-14 06:01:32
Documents
13
Period of Report
2023-04-11
Items
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K e4593_8-k.htm   iXBRL 8-K 27555
2 EXHIBIT 3.1 e4593_ex3-1.htm EX-3.1 69406
  Complete submission text file 0001731122-23-000651.txt   287190

Data Files

Seq Description Document Type Size
3 XBRL SCHEMA FILE avxl-20230411.xsd EX-101.SCH 3221
4 XBRL LABEL FILE avxl-20230411_lab.xml EX-101.LAB 34240
5 XBRL PRESENTATION FILE avxl-20230411_pre.xml EX-101.PRE 22355
7 EXTRACTED XBRL INSTANCE DOCUMENT e4593_8-k_htm.xml XML 3716
Mailing Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163
Business Address 51 W 52ND STREET, 7TH FLOOR NEW YORK NY 10019-6163 800-689-3939
ANAVEX LIFE SCIENCES CORP. (Filer) CIK: 0001314052 (see all company filings)

IRS No.: 208365999 | State of Incorp.: NV | Fiscal Year End: 0930
Type: 8-K | Act: 34 | File No.: 001-37606 | Film No.: 23819602
SIC: 2836 Biological Products, (No Diagnostic Substances)